Clinical Trial

Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy

Study acronym: breast cancer
Completed
View on ClinicalTrials.gov →
Summary
Breast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress is also a major issue in cancer care. This study integrates mobile health information with a nurse-led communication support plan, aiming to improve patients' physical and mental outcomes during chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-21.
Status change: Recruiting → Completed 2026-06-29
Trial Details
NCT Number NCT06949046
Lead Sponsor National Defense Medical Center, Taiwan
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment 80 participants
Start Date 2024-08-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01